Morgan Stanley’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.5M Sell
407,771
-33,162
-8% -$3.16M ﹤0.01% 2223
2025
Q4
$35.8M Buy
440,933
+19,327
+5% +$1.66M ﹤0.01% 2405
2025
Q3
$36.9M Buy
421,606
+13,014
+3% +$1.16M ﹤0.01% 2283
2025
Q2
$33.9M Buy
408,592
+40,648
+11% +$3.4M ﹤0.01% 2282
2025
Q1
$30.9M Sell
367,944
-35,062
-9% -$3.26M ﹤0.01% 2260
2024
Q4
$37.1M Buy
403,006
+31,019
+8% +$2.98M ﹤0.01% 2111
2024
Q3
$34.6M Buy
371,987
+52,078
+16% +$4.51M ﹤0.01% 2223
2024
Q2
$26.3M Buy
319,909
+26,143
+9% +$1.92M ﹤0.01% 2373
2024
Q1
$19.5M Sell
293,766
-295,482
-50% -$18.2M ﹤0.01% 2725
2023
Q4
$33.4M Buy
589,248
+336,239
+133% +$17.6M ﹤0.01% 2863
2023
Q3
$13.8M Sell
253,009
-19,358
-7% -$1.15M ﹤0.01% 2830
2023
Q2
$18.3M Buy
272,367
+63,158
+30% +$3.85M ﹤0.01% 2565
2023
Q1
$10.8M Sell
209,209
-11,589
-5% -$563K ﹤0.01% 3077
2022
Q4
$10.2M Buy
220,798
+3,356
+2% +$157K ﹤0.01% 3076
2022
Q3
$11M Buy
217,442
+12,791
+6% +$639K ﹤0.01% 2856
2022
Q2
$9.32M Buy
204,651
+99,028
+94% +$4.43M ﹤0.01% 3135
2022
Q1
$4.91M Sell
105,623
-12,242
-10% -$548K ﹤0.01% 3706
2021
Q4
$5.92M Sell
117,865
-73,802
-39% -$3.82M ﹤0.01% 3542
2021
Q3
$10.2M Buy
191,667
+32,069
+20% +$1.81M ﹤0.01% 2872
2021
Q2
$9.74M Sell
159,598
-143,397
-47% -$7.62M ﹤0.01% 3021
2021
Q1
$14.8M Buy
302,995
+115,111
+61% +$5.39M ﹤0.01% 2239
2020
Q4
$7.61M Buy
187,884
+119,797
+176% +$4.28M ﹤0.01% 2808
2020
Q3
$2.21M Sell
68,087
-149,012
-69% -$4.47M ﹤0.01% 3566
2020
Q2
$5.73M Buy
217,099
+92,901
+75% +$2.43M ﹤0.01% 2532
2020
Q1
$3.1M Sell
124,198
-92,624
-43% -$2.86M ﹤0.01% 2934
2019
Q4
$7.79M Buy
216,822
+43,947
+25% +$1.52M ﹤0.01% 2689
2019
Q3
$5.91M Sell
172,875
-29,797
-15% -$952K ﹤0.01% 2681
2019
Q2
$5.67M Buy
202,672
+122,152
+152% +$3.39M ﹤0.01% 2793
2019
Q1
$2.5M Sell
80,520
-14,792
-16% -$395K ﹤0.01% 3393
2018
Q4
$2.25M Buy
95,312
+33,064
+53% +$903K ﹤0.01% 3664
2018
Q3
$2.41M Sell
62,248
-8,991
-13% -$324K ﹤0.01% 3861
2018
Q2
$2.39M Sell
71,239
-13,754
-16% -$489K ﹤0.01% 3907
2018
Q1
$3.08M Sell
84,993
-16,146
-16% -$559K ﹤0.01% 3576
2017
Q4
$3.22M Sell
101,139
-64,156
-39% -$2.2M ﹤0.01% 3559
2017
Q3
$6.18M Sell
165,295
-10,269
-6% -$349K ﹤0.01% 2733
2017
Q2
$5.48M Sell
175,564
-4,234
-2% -$122K ﹤0.01% 2744
2017
Q1
$4.43M Buy
179,798
+5,775
+3% +$136K ﹤0.01% 2971
2016
Q4
$4.41M Sell
174,023
-74,342
-30% -$1.65M ﹤0.01% 3128
2016
Q3
$4.93M Buy
248,365
+40,458
+19% +$707K ﹤0.01% 2668
2016
Q2
$2.97M Buy
207,907
+18,068
+10% +$276K ﹤0.01% 3094
2016
Q1
$2.95M Sell
189,839
-57,493
-23% -$824K ﹤0.01% 3009
2015
Q4
$4.27M Buy
247,332
+3,958
+2% +$57.3K ﹤0.01% 2821
2015
Q3
$2.97M Buy
243,374
+228,749
+1,564% +$2.93M ﹤0.01% 3136
2015
Q2
$176K Buy
14,625
+14,582
+33,912% +$144K ﹤0.01% 5306
2015
Q1
$0 Buy
43
+14
+48% +$110 ﹤0.01% 6601
2014
Q4
$0 Hold
29
﹤0.01% 6618
2014
Q3
$0 Sell
29
-3,420
-99% -$25.5K ﹤0.01% 6614
2014
Q2
$29K Sell
3,449
-921
-21% -$7.2K ﹤0.01% 5928
2014
Q1
$35K Sell
4,370
-9,131
-68% -$73K ﹤0.01% 5828
2013
Q4
$108K Buy
+13,501
New +$104K ﹤0.01% 5322

Other funds holding LMAT

Morgan Stanley's LMAT Position: Q1 2026 in Review

Morgan Stanley reduced its LeMaitre Vascular (LMAT) stake by 7.5% in Q1 2026, selling an estimated $3.16M and leaving 407,771 shares worth $44.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2223.

Morgan Stanley first reported a position in LMAT in Q4 2013 and has held it in 50 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Morgan Stanley held 407,771 shares of LeMaitre Vascular worth $44.5M as of Q1 2026.
  • Morgan Stanley sold 33,162 LeMaitre Vascular shares in Q1 2026, an estimated $3.16M.
  • LeMaitre Vascular made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2223 holding.
  • Morgan Stanley first reported a position in LeMaitre Vascular in Q4 2013 and has held it in 50 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.